| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Common Stock | Options Exercise | +8,250 | +512% | 9,860 | 15 Jul 2022 | Direct | F1, F2 | ||
| transaction | GBIO | Common Stock | Tax liability | $17,390 | -2,422 | -25% | $7.18 | 7,438 | 15 Jul 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -8,250 | -25% | $0.000000 | 24,750 | 15 Jul 2022 | Common Stock | 8,250 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
| F2 | Includes 1,610 shares acquired under the company's employee stock purchase plan since February 10, 2022. |
| F3 | On January 21, 2022, the reporting person was granted 33,000 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. |